We have located links that may give you full text access.
Performance Standards for Biological Threat Agent Assays for Department of Defense Applications.
Journal of AOAC International 2018 August 23
There has been a proliferation in the developmentof biological threat agent detection technologies foruse in the field by first responders and private-sectorend-users as well as in Department of Defense(DoD) applications in which active combat maybe occurring and in other parts of the world. Incontrast to the proliferation of detection methodology,there has been a lack of standards defining therequired performance of these technologies. Standardsare necessary to demonstrate the performanceand limitations of the tools, providing confidencein the data to allow appropriate response actions byend-users and responders. In the past, the Departmentof Homeland Security (DHS), Science andTechnology Directorate, funded AOAC to developstandards and perform conformity assessmentunder three efforts. The first effort began in 2003to evaluate the performance of lateral flow immunoassaydevices used by first responders to screensuspicious powders for Bacillus anthracis spores.These devices are colloquially known as "handheldassays" and are frequently referred to as"HHAs." AOAC formed the Task Force on Bacillusanthracis (TFBA), which created a specific set ofconsensus performance criteria and test protocols(i.e., standards). Five HHA manufacturers submittedtheir technologies to AOAC so that third-partylaboratories could evaluate the tools against thecriteria.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app